Nanocarrier-empowered aggregation-induced luminescence and its therapeutic promise in oncology

Key Points

• The aim is to explore challenges in using aggregation-induced emission (AIE) agents and their combination with nanocarriers for cancer treatment.
• Systematic review of existing literature on AIEgen applications and challenges.
• Analysis of biocompatibility and safety issues associated with AIEgens in vivo.
• Evaluation of strategies to improve AIEgen effectiveness using nanocarrier technology.
• Identified significant limitations in current AIEgen applications for oncology.
• Proposed solutions involving nanocarriers to enhance biocompatibility and safety.
• Recommended strategies indicate promising pathways for therapeutic advancements.